Neurology : 前循环脑梗前,若存在运动障碍,预后如何?

2021-09-26 Freeman MedSci原创

https://pubmed.ncbi.nlm.nih.gov/34544817/

AHA/ASA指南建议为符合条件的缺血性卒中患者提供血管血栓切除术(EVT),其病前修改的Rankin量表(mRS)<2.病前残疾(mRS≥2)的患者基本上被排除在关键的EVT试验之外。

然而,病前中度至重度残疾的患者,占所有缺血性卒中患者的三分之一。

此外,最近在美国进行的一项双中心研究显示,病前mRS≥2的患者占真实世界EVT病例的34%,与病前mRS 0-1的患者相比,根据mRS评分从卒中前到90天的变化,显示出与病前残疾水平相似的恢复。

之前的一项多中心观察性研究报告了类似的结果,但仅限于欧洲的中心。然而,在美国的中心,还没有进行过一项关于用EVT和第二代支架植入器治疗的病前mRS≥2的多中心研究。

为了给这样的试验提供更多的证据,需要一个前瞻性的随机临床试验来确定EVT对病前残疾患者的益处,

藉此,美国University of Utah的Adam de Havenon在一个大型的、多中心的、注册数据,研究了病前残疾对EVT后结果的影响。

他们对TREVO支架-复位器急性卒中(TRACK)登记处进行了事后分析,该登记处收集了美国23个中心使用Trevo设备作为一线EVT治疗的634名连续卒中患者的数据。

他们纳入了颈内动脉或大脑中段(M1/M2段)闭塞的患者,研究暴露为患者或护理人员报告的病前改良等级表(mRS)≥2(病前残疾,PD)与病前mRS评分0-1(无病前残疾,NPD)。

主要结果是没有累积残疾,定义为90天的mRS与患者病前的mRS相比没有增加。

在TRACK的634名患者中,407名患者被纳入我们的队列,其中53/407(13.0%)患有PD。37.7%(20/53)的PD患者和16.7%(59/354)的NPD患者达到了无累积残疾的主要结果(P<0.001),而39.6%(21/53)和14.1%(50/354)的患者发生死亡(P<0.001)。

与NPD患者相比,PD患者无累积残疾的调整后几率为5.2(95% CI 2.4-11.4,p<0.001)。然而,PD患者死亡的调整后几率为2.90(95% CI 1.38-6.09,p=0.005)。


在这项对前循环急性缺血性卒中患者进行EVT治疗的研究中,他们发现,与没有前循环残疾的患者相比,前循环残疾与不积累更多残疾的概率有关,但也与更高的死亡概率有关。


原文出处:
de Havenon A, Castonguay A, Nogueira R, et al. Prestroke Disability and Outcome After Thrombectomy for Emergent Anterior Circulation Large Vessel Occlusion Stroke. Neurology. Published online September 20, 2021:10.1212/WNL.0000000000012827. doi:10.1212/WNL.0000000000012827

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2001492, encodeId=601f2001492f0, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 10 21:24:16 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819970, encodeId=e01718199e036, content=<a href='/topic/show?id=4bf410018055' target=_blank style='color:#2F92EE;'>#预后如何#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100180, encryptionId=4bf410018055, topicName=预后如何)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Wed Dec 08 05:24:16 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368812, encodeId=f7201368812c1, content=<a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94238, encryptionId=b40b9423884, topicName=运动障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Sep 28 12:24:16 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465215, encodeId=8f4e1465215b2, content=<a href='/topic/show?id=2dea8489010' target=_blank style='color:#2F92EE;'>#脑梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84890, encryptionId=2dea8489010, topicName=脑梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccf56689148, createdName=karmond, createdTime=Tue Sep 28 12:24:16 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055328, encodeId=db81105532829, content=学习了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 27 13:13:01 CST 2021, time=2021-09-27, status=1, ipAttribution=)]
    2022-08-10 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2001492, encodeId=601f2001492f0, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 10 21:24:16 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819970, encodeId=e01718199e036, content=<a href='/topic/show?id=4bf410018055' target=_blank style='color:#2F92EE;'>#预后如何#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100180, encryptionId=4bf410018055, topicName=预后如何)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Wed Dec 08 05:24:16 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368812, encodeId=f7201368812c1, content=<a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94238, encryptionId=b40b9423884, topicName=运动障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Sep 28 12:24:16 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465215, encodeId=8f4e1465215b2, content=<a href='/topic/show?id=2dea8489010' target=_blank style='color:#2F92EE;'>#脑梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84890, encryptionId=2dea8489010, topicName=脑梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccf56689148, createdName=karmond, createdTime=Tue Sep 28 12:24:16 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055328, encodeId=db81105532829, content=学习了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 27 13:13:01 CST 2021, time=2021-09-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2001492, encodeId=601f2001492f0, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 10 21:24:16 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819970, encodeId=e01718199e036, content=<a href='/topic/show?id=4bf410018055' target=_blank style='color:#2F92EE;'>#预后如何#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100180, encryptionId=4bf410018055, topicName=预后如何)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Wed Dec 08 05:24:16 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368812, encodeId=f7201368812c1, content=<a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94238, encryptionId=b40b9423884, topicName=运动障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Sep 28 12:24:16 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465215, encodeId=8f4e1465215b2, content=<a href='/topic/show?id=2dea8489010' target=_blank style='color:#2F92EE;'>#脑梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84890, encryptionId=2dea8489010, topicName=脑梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccf56689148, createdName=karmond, createdTime=Tue Sep 28 12:24:16 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055328, encodeId=db81105532829, content=学习了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 27 13:13:01 CST 2021, time=2021-09-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2001492, encodeId=601f2001492f0, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 10 21:24:16 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819970, encodeId=e01718199e036, content=<a href='/topic/show?id=4bf410018055' target=_blank style='color:#2F92EE;'>#预后如何#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100180, encryptionId=4bf410018055, topicName=预后如何)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Wed Dec 08 05:24:16 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368812, encodeId=f7201368812c1, content=<a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94238, encryptionId=b40b9423884, topicName=运动障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Sep 28 12:24:16 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465215, encodeId=8f4e1465215b2, content=<a href='/topic/show?id=2dea8489010' target=_blank style='color:#2F92EE;'>#脑梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84890, encryptionId=2dea8489010, topicName=脑梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccf56689148, createdName=karmond, createdTime=Tue Sep 28 12:24:16 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055328, encodeId=db81105532829, content=学习了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 27 13:13:01 CST 2021, time=2021-09-27, status=1, ipAttribution=)]
    2021-09-28 karmond
  5. [GetPortalCommentsPageByObjectIdResponse(id=2001492, encodeId=601f2001492f0, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Aug 10 21:24:16 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819970, encodeId=e01718199e036, content=<a href='/topic/show?id=4bf410018055' target=_blank style='color:#2F92EE;'>#预后如何#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100180, encryptionId=4bf410018055, topicName=预后如何)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f612331, createdName=gds2009, createdTime=Wed Dec 08 05:24:16 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368812, encodeId=f7201368812c1, content=<a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94238, encryptionId=b40b9423884, topicName=运动障碍)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Sep 28 12:24:16 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465215, encodeId=8f4e1465215b2, content=<a href='/topic/show?id=2dea8489010' target=_blank style='color:#2F92EE;'>#脑梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84890, encryptionId=2dea8489010, topicName=脑梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccf56689148, createdName=karmond, createdTime=Tue Sep 28 12:24:16 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055328, encodeId=db81105532829, content=学习了,不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 27 13:13:01 CST 2021, time=2021-09-27, status=1, ipAttribution=)]
    2021-09-27 onebutton

    学习了,不错不错

    0

相关资讯

Stroke: 脑卒中前运动障碍, 行血管内治疗,其结局如何?

虽然PSMI患者的程序性不良后果并不高,但有必要进一步研究以确定这一人群的临床益处。

Stroke:慢性病基础,或解释不同种族的脑中风预后差异

MAs的年龄调整后的MCC负担较高,这部分解释了FO的种族差异

Stroke:脑中风后,经食管心脏超声,有何益处?

在未确定病因的卒中患者中,TEE比TTE产生了更多与治疗相关的发现

Neurology:卒中后心房颤动检测的生物标志物:系统评价和荟萃分析

研究确定了多模式生物标志物,它们可以帮助指导缺血性卒中/短暂性脑缺血发作(TIA)后心脏监测的患者选择。他们的预后效用应该以房颤检测和复发卒中作为结果进行前瞻性评估。

JNER:Kickstart步行辅助系统改善脑卒中患者平衡和步行功能的可行性研究

近三分之一的中风发生在65岁以上的人群中,大多数中风患者都有行走障碍。肌肉质量和肌力的减少经常会阻碍他们的日常活动,限制他们在床上活动,反而更加速神经肌肉系统的退化。由治疗师为中风患者提供的常规步态疗

Stroke:慢性隐性脑梗塞,有哪些表型特点?

在AIS患者中,那些有额外CBI的患者代表了一个血管高危亚组,不同表型的CBI与不同的危险因素谱的关联可能会指向具有鉴别性的AIS病因。

拓展阅读

【协和医学杂志】卒中后中枢性疼痛的诊断及治疗进展

本文从CPSP的临床特征、流行病学、发病机制及治疗手段等方面展开综述,以期为CPSP的诊断及有效治疗提供参考。

卒中计划早期诊断评分表(ASPECTS评分)

卒中计划早期诊断评分表(ASPECTS评分)

SVN:系统性红斑狼疮患者中风风险的十年跟踪调查

系统性红斑狼疮患者发生持续10年的缺血性中风的风险仍增高,同时由于出血性中风的风险,系统性红斑狼疮患者应谨慎使用抗血小板药物,以预防心血管事件的发生。

European Radiology:聚焦CT血管造影选择性显示卒中相关动脉的技术可行性

现阶段,深度学习彻底改变了图像后处理,并可用于许多医学图像执行任务。

神经科一周速递:热点解读进展大盘点!

一周热点分享 ,紧跟神经科学前沿,让每一次诊疗都更精准,点击立即查看!

Stroke:卒中与癫痫风险—— 一项基于丹麦全国登记的研究

脑卒中后癫痫的绝对和相对风险估计值均低于之前的研究。

脑卒中一级预防的最佳证据总结

暂未更新 · 2024-01-10

成人脑卒中患者久坐行为管理的最佳证据总结

南昌大学护理学院 · 2024-01-10

脑卒中后认知功能障碍危险因素管理的证据总结

广西中医药大学护理学院 · 2023-10-01